300-075 actual test 70-346 answer analysis 200-310 actual questions 70-532 practice exam exambestpdf.com

Biggest Pharmaceutical Formulation Companies | Exporter | Manufacturers in India | Novel Drug Delivery Solutions (NDDS) | Pre Formulation Intermediates | WHO-GMP Approved Manufacturer | EU-GMP Certified Company India

ABOUT US

Our Vision

With a Vision of Making Quality Healthcare Affordable Through Drug Delivery Solutions Focusing On Patient Convenience and Adherence, ZIM’s value propositions is its ability to provide a range of technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for development, manufacture and supply of innovative and differentiated generic pharmaceutical products to its customers globally.

OUR VALUES

Zim Labs has technology backed solutions that enables catering across various therapeutic segments such as

tech

Cardiovascular

tech

Anti-infective

tech

Gastrointestinal

tech

Respiratory system

tech

Nervous system

tech

Musculoskeletal

tech

Haematology system

tech

Vitamins

Our innovative technology solutions include drug release profile modifications, solubility & stability enhancement, taste masking and dosage form transformation

HISTORY & PATH FORWARD
An overview of Zim Labs at a glance from its inception, current offerings to its path forward and the leadership behind the journey.

ZIM IN FOCUS

Over time ZIM has created a long term sustainable advantage by focused on Novel Drug Delivery Solutions (NDDS) segment through continuous innovation and development of non-infringing technology platforms and supply of high quality products at competitive prices.

The Company is led by an experienced technocrat who is supported by a well-qualified professional management team.

R&D capabilities & manufacturing skills to develop & supply differentiated generic products, in pre-formulation dosage forms, to business partners who need comprehensive support in product development, full mfg technical training, registration & sourcing of such differentiated products to boost their pipeline & compete.

ZIM has three manufacturing blocks (General, Cephalosporin and OTF). ZIM general block is EU-GMP and WHO-GMP approved. Its Cephalosporin and OTF blocks are WHO-GMP approved. ZIM is amongst the few companies in India to receive WHO-GMP approval for its OTF facility.

ZIM supplies a wide range of solid dosage differentiated products across various therapeutic segments. ZIM is a pioneer in the OTF technology in India and focussed on growing this platform in partnership with marketing companies and product originators.

• Developing new technology platforms & differentiated generic products for itself and under license arrangement.
• Manufacturing and supply of finished and semi-finished formulations for RoW
• Development of the Thin Film as an alternate delivery platform

ZIM has a state of the art R&D centre with a team of over 90 professionals. ZIM is now setting up a new R&D centre with team, equipment and capabilities targeted for developed markets.

The Company has improved its EBITDA Margins from 11% to 15% in last four years on account of continued focus on high margin businesses.

ACCREDITATIONS

Our facilities are accredited with respected certifications from authorized independent bodies, which are generally accepted worldwide as a mark of approval of the quality of the manufacturer’s operational capabilities. These accreditations are: